Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP & Chief Operating Officer | November 27, 2023 | November 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date November 27, 2023 · Filed November 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,338 |
Ending reported balance
After 2023-11-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-27 · Exercise / conversion · Acquired 406 · Balance 6,479 Row 2 · 2023-11-27 · Tax withholding · Disposed 141 · Balance 6,338 F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 813 |
Reported balance
After 2023-11-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-11-27 · Exercise / conversion · Disposed 406 · Balance 813 F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |
| Common StockSEC Table I · non-derivative | IndirectBerger Family Trust | 242 |
Reported balance
Holding disclosure · report date 2023-11-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 242 F2: The securities are held by the Berger Family Trust dated April 16, 2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2: The securities are held by the Berger Family Trust dated April 16, 2008.
F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2022 Filed Aug 31, 2022 20:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000199 · wf-form4_166197845553750.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,845 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 20:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 202 | $46.68 | $9,429.36 |
DisclosureSEC source: 0001438133-22-000199 · wf-form4_166197845553750.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,743 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 20:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000199 · wf-form4_166197845553750.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000185 · wf-form4_166076982986993.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 81 | $55.25 | $4,475.25 |
DisclosureSEC source: 0001438133-22-000185 · wf-form4_166076982986993.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,538 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000185 · wf-form4_166076982986993.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 7,000 | $18.86 Strike: $18.86 | $132,020.00 |
DisclosureSEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 7,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted on 6/14/2018 vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan"). F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 3,097 | $65.00 | $201,305.00 |
DisclosureSEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,457 Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 7,000 | $65.03 | $455,210.00 |
DisclosureSEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,554 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.00 to $65.10. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 7,000 | $18.86 | $132,020.00 |
DisclosureSEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:15 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000143 · wf-form4_165412888804851.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,252 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:15 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 202 | $70.81 | $14,303.62 |
DisclosureSEC source: 0001438133-22-000143 · wf-form4_165412888804851.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,554 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:15 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000143 · wf-form4_165412888804851.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 8,544 | $0.00 Strike: $65.28 | $0.00 |
DisclosureSEC source: 0001438133-22-000128 · wf-form4_165370252215867.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544 Underlying: Common Stock · 8,544 shares Expires not disclosed F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.exercise_date: The option shall vest as to thirty-three percent (33%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in twenty-four (24) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantPerformance Stock Unit · Derivative | 5,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000128 · wf-form4_165370252215867.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,523 Underlying: Common Stock · 5,523 shares Expires not disclosed F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F5 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F5 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 5,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000128 · wf-form4_165370252215867.xml · derivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,691 Underlying: Common Stock · 5,691 shares Expires not disclosed F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the2013 Plan. F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Underlying: Common Stock · 650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 306 | $61.17 | $18,718.02 |
DisclosureSEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,350 F2 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2021 through May 16, 2022. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 323 | $73.85 | $23,853.55 |
DisclosureSEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000046 · wf-form4_164919133994445.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,000 | $117.88 | $117,879.80 |
DisclosureSEC source: 0001438133-22-000046 · wf-form4_164919133994445.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,717 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.77 to $118.39. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000046 · wf-form4_164919133994445.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| March 16, 2022 Filed Mar 21, 2022 22:26 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 5,000 | $18.86 Strike: $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-22-000041 · wf-form4_164790157987932.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| March 16, 2022 Filed Mar 21, 2022 22:26 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 5,000 | $108.37 | $541,843.00 |
DisclosureSEC source: 0001438133-22-000041 · wf-form4_164790157987932.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,717 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.23 to $108.76. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| March 16, 2022 Filed Mar 21, 2022 22:26 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 5,000 | $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-22-000041 · wf-form4_164790157987932.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · derivative · entry 7 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,000 | $112.68 | $112,680.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,717 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 141 | $112.43 | $15,852.63 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,717 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 358 | $118.89 | $42,562.62 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.04. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 400 | $117.78 | $47,112.00 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,809 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.12. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 242 | $116.67 | $28,234.14 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.36 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 170 | $150.40 | $25,568.00 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.31 to $150.52. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 830 | $148.91 | $123,595.30 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,621 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $148.78 to $149.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:35 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 12,000 | $18.86 Strike: $18.86 | $226,320.00 |
DisclosureSEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:35 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 12,000 | $144.25 | $1,731,000.00 |
DisclosureSEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:35 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 12,000 | $18.86 | $226,320.00 |
DisclosureSEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · derivative · entry 8 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 100 | $129.61 | $12,961.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 900 | $128.31 | $115,479.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,551 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $127.97 to $128.75. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · derivative · entry 7 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 202 | $129.66 | $26,191.32 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.